of UC can be potentially toxic and long-term fasting and total parenteral nutrition is sometimes necessary for patients. The anti-colitis effects of probiotic or symbiotic administration have been reported in patients with limited mild UC (4, 5) . However, effective nutritional therapies for UC have not been fully investigated in contrast to Crohn's disease. Therefore, it may be beneficial to investigate the safety effects of dietary factors in the management of UC.
Tryptophan, an essential amino acid in mammals, is a precursor for biosynthesis of serotonin via the kynurenine pathway in human beings. Recently, the protective effect of L-tryptophan administration on dextran sulfate sodium (DSS)-induced colitis by the reduction of pro-inflammatory cytokines and activation of apoptosis initiators was reported (6) . However, the anti-oxidative and anti-nitration effects of tryptophan or its metabolites have not previously been investigated.
Oxidative stress or nitration stress are involved in the severity and pathogenicity of UC (3) . Enhanced release of reactive oxygen species (ROS) such as superoxide, hydroxyl radical and reactive nitrogen species (RNS) such as peroxynitrite via nitric oxide (NO), play aggravated roles in both clinical UC and DSS-induced colitis animal models (7) . The excess generation of superoxide or NO is often cytotoxic and can induce tissue damage. Moreover, superoxide reacts rapidly to NO and induces the generation of peroxynitrite which is a strong cytotoxic, leading to severe tissue damage (8, 9) . Nitrotyrosine is widely used as a marker for the generation of peroxynitrite.
The relationship between the ameliorative effects against colitis and the anti-oxidative or nitration effects of tryptophan administration have not been investigated, although one study has reported the protective effect of tryptophan administration against DSS-induced colitis in an animal model (6) . In this study, the mechanism of the protective effect of tryptophan administration on DSS-induced colitis model in mice was examined using an assay of nitro compounds in light of its anti-oxidative and nitration effects.
MATERIALS AND METHODS
Experimental procedures were reviewed and approved by the Animal Experimentation Committee, School of Medicine, Tokai University, Japan.
Experimental animal model
Twenty C57black6 female mice (6 weeks of age) were obtained from CLEA Japan Inc. (Tokyo, Japan) and bred under specific pathogen-free conditions at a room temperature of 25 °C, with a 12-h light/dark cycle. These mice were randomized into two dietary groups. The control group (10 mice) received a standard CE-2 diet and the tryptophan group (10 mice) received a CE-2 diet containing 0.5% l-tryptophan. The standard CE-2 diet was supplied by CLEA Japan Inc. (Tokyo, Japan), while the CE-2 diet containing l-tryptophan was supplied by Sakamoto Kurozu Inc. (Kagoshima, Japan). The diets were started a week prior to the initial administration of DSS. In both groups, a 3.5% solution of DSS (Sigma-Aldrich, St. Louis, USA) in water was orally administered for 12 days to induce colitis. In addition to the 2 groups, 10 mice receiving a standard CE-2 diet did not receive DSS.
Evaluation of manifestations in mice
Changes in body weight and bloody stool frequency were monitored as indices of severity of colitis every 2 days for 12 days after the initial administration of DSS. The mean body weight and standard deviation (SD) was calculated. Body weight changes after DSS administration were compared as a calculated percentage of the basal body weight before DSS administration (taken as 100%). Bloody stool frequency in mice after DSS administration is shown as a percentage in each group (number of animals with bloody stool/ total number of animalsx100%). All mice were sacrificed under isoflurane anesthesia (Wako Pure Chemicals, Osaka, Japan) at 12 days after initial DSS administration. The proximal middle colon was then resected.
Histological examination
For microscopic examination, resected colonic tissues from all animals were fixed in buffered formaldehyde, embedded in paraffin, sectioned and stained with hematoxylin and eosin (H.E.).
Nitrotyrosine assay in colonic tissues
Nitrotyrosine levels of resected colon tissues at 12 days after initial DSS administration were measured using a commercial enzyme-linked immunosorbent assay (ELISA). Values are presented as a mean with the SD. Resected colon tissues were homogenized by centrifugation at 20,000×g (20 min), and the supernatant was examined with a Nitrotyrosine ELISA Kit, NWLSS (2×96 well) (Funakos-hi Co., Osaka, Japan) according to the manufacturer's instructions. The absorbance at 450 nm was measured.
Nitrate and nitrite assay in urine
Urinary excretion/day (measured for 11-12 days after initial DSS administration) of nitrate and nitrite (NOx) as a parameter of the bioavailability of NO was measured by the Griess method (Griess reagent kit; Invitrogen Japan K.K., Tokyo, Japan) for all three groups; the (DSS-induced) control group, the tryptophan group, and the group of mice which received the standard CE-2 diet without administration of DSS (each group; n=10).
Statistical analysis
The significance of differences in body weight at 2-12 days after administration of DSS and nitrotyrosine levels between the two groups was evaluated by means of unpaired t-tests. Frequency of bloody stool at 2 -12 days after DSS administration was analyzed using contingency tables.
Differences in NOx levels among the three groups were statistically analyzed by means of one-way analysis of variance (ANOVA) followed by Tukey's multiple comparison post-hoc test. The criterion of significance was set at p<0.05.
RESULTS
Body weight reduction was significantly attenuated in the tryptophan group throughout days 2-12 after the initial DSS administration, compared with the control group (p<0.01) ( Table 1) .
Bloody stool was observed in 9 out of 10 mice (90%) in the control group on day 2, and in all them (100%) during days 4-12. Tryptophan treatment significantly (p<0.01) reduced the frequency of bloody stool throughout days 2-12 compared with the control group, and the bloody stool frequency at day 12 was only 10% (Table 2) .
HE staining of resected colon tissue revealed epithelial abrasions, cryptal disturbance, and inflammatory cell infiltration in mucosa and submucosal areas of colon in the control group ( Figure 1A) . Again, tryptophan treatment remarkably suppressed these changes ( Figure 1B ).
Nitrotyrosine levels in resected colonic tissues was significantly (p<0.01) reduced to 61.1±11.0 ng/g protein in the tryptophan group, Compared to 87.8±7.4 ng/g protein in the control group (Figure 2 ).
NOx levels in urine (μM/day) in the (DSS-induced) control group (821±181) and the tryptophan group (780±162) were significantly increased when compared to mice without DSS administration group (521±82).
However, there were no siginificant differences between the (DSS-induced) control group and the tryptophan group (Figure 3 ).
DISCUSSION
Our study revealed that tryptophan treatment ameliorated DSS-induced colitis in mice, and significantly reduced nitrotyrosine level in colon tissues, did not influence the level of NOx in urine.
Nitrotyrosine is produced in vivo via two pathways, i.e., from the reaction of tyrosine with peroxynitrite, which is generated from superoxide and NO (8) , and from the reaction of tyrosine with Therefore, tryptophan or its metabolites are estimated to suppress the generation of superoxide or MPO because theoretically, reduction of nitrotyrosine is via whether suppression of reaction of superoxide and NO or MPO and nitrite Superoxide, or its products may play roles in amelioration of colitis and reduction of nitrotyrosine level in this study. Excessive generation of superoxide is cytotoxic. Moreover, nitrotyrosine generation is via nitration of tyrosine residues by peroxynitrite which has cytotoxicity and induces severe tissue damage (9, 10) . Since peroxynitrite is generated by rapid reaction of superoxide and NO, suppression of superoxide generation may be potent mechanism of anti-colitis effect of tryptophan treatment. Still over, superoxide is generally catabolized hydrogen pero-F Fi ig gu ur re e 1 1. . H Hi is st to ol lo og gi ic ca al l f fi in nd di in ng gs s o of f r re es se ec ct te ed d c co ol lo on n HE staining of resected colons revealed abrasions of epithelium, cryptal disturbance, and inflammatory cell infiltration in mucosa and submucosal areas of colon in the control group. The tryptophan treatment remarkably attenuated these changes in comparison to the control group (A; the control group, B; the tryptophan group).
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xide (H 2 O 2 ) by superoxide dismutase (SOD). H 2 O 2 is induced generation of hydroxyl radical which has strong oxidative effect and tissue damage under the some conditions such as Fenton's reaction. Therefore, suppression of superoxide is estimated to inhibit of generation of peroxynitrite or hydroxyl radical, followed by amelioration of colitis and reduction of nitrotyrosine generation.
Cytotoxicity of MPO itself has been discussable (11) . In this study, tryptophan treatment remarkably ameliorated inflammatory cell infiltration of the colon. Since MPO is mainly included in neutrophils, possibility that tryptophan or its metabolites reduce the release of MPO from neutrophils is undeniable. Therefore, suppression of MPO is undeniable as possibile mechanism of suppression of nitrotyrosine although anti-colitis effects of MPO are unknown at present.
Tryptophan is metabolized via several pathways. Main are kynurenine pathway in human. 3-Hydroxyanthranilic acid (3-HA) and 3-hydroxykynurenine (3-HK) are metabolized via kynurenine pathway. However, these metabolites have been reported rather cofactors in the oxidative damage (12, 13) . Another metabolite, 5-hydrotryptamine (5-HT), was reported to be involved in the pathogenesis of inflammation in experimental colitis (14) . Moreover, 5-HT have been reported to accelerate NO production via endothelial NOS (eNOS) in vitro (15) .
On the other hand, indole derivatives via kynurenine pathway have been reported to have anti-oxidative effects as scavengers of peroxynitrite (16) . Moreover, serotonin, 5-hydroxytryptophan (5-HTP), N-acetylserotonin (NAS), and melatonin which are metabolized via serotonin pathway have been reported to have several anti-oxidative effects (17) (18) (19) (20) . Serotonin, NAS, melatonin have been reported to have suppressive effects of superoxide generation. Still over, 5-HTP, precursor of serotonin has been reported to reduce the oxidative damage by suppression of ROS or peroxynitrite (21) . Nevertheless melatonin is directly scavengers a variety of free radicals and an indirect antioxidant (22) , a contribution of melatonin can be ruled out in the present model because C57black6 mice do not synthesize melatonin.
Therefore, we hypothesized that metabolites such as indole derivatives, serotonin, 5-HTP and NAS may be candidates to play key roles of suppression of superoxide or peroxynitrite, and ameliorated DSS-induced colitis and reduced nitrotyrosine level in this study.
In conclusion, our study indicate that tryptophan treatment ameliorated DSS-induced colitis, and one of the anti-colitis mechanism may be anti-oxidative or nitration stress although contributions of these compounds to the protective effect of tryptophan remain to be addressed.
